Literature DB >> 8862507

Oral glucose tolerance test: an inhibitory or a stimulatory input to growth hormone secretion?

R Valcavi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8862507     DOI： 10.1007/BF03349877

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  24 in total

Review 1.  Interrelationship of somatostatin and growth hormone-releasing hormone in the genesis of the rhythmic secretion of growth hormone.

Authors:  G S Tannenbaum
Journal:  Acta Paediatr Scand Suppl       Date:  1990

2.  Prevention of L-dopa-induced growth hormone stimulation by hyperglycemia.

Authors:  R B Mims; C L Scott; O M Modebe; J E Bethune
Journal:  J Clin Endocrinol Metab       Date:  1973-11       Impact factor: 5.958

3.  The effect of intravenous glucose infusion on the exercise-induced serum growth hormone rise in normals and juvenile diabetics.

Authors:  A P Hansen
Journal:  Scand J Clin Lab Invest       Date:  1971-10       Impact factor: 1.713

4.  Impairment of hyperglycemic induced growth hormone suppression in hyperthyroidism.

Authors:  A Vinik; B Pimstone; B Buchanan-Lee
Journal:  J Clin Endocrinol Metab       Date:  1968-11       Impact factor: 5.958

5.  Defective suppression of growth hormone after oral glucose loading in adolescence.

Authors:  G F Pieters; A G Smals; P W Kloppenborg
Journal:  J Clin Endocrinol Metab       Date:  1980-08       Impact factor: 5.958

6.  Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin?

Authors:  A Peñalva; B Burguera; X Casabiell; J A Tresguerres; C Dieguez; F F Casanueva
Journal:  Neuroendocrinology       Date:  1989-05       Impact factor: 4.914

7.  Oral glucose inhibits growth hormone secretion induced by human pancreatic growth hormone releasing factor 1-44 in normal man.

Authors:  R R Davies; S Turner; D G Johnston
Journal:  Clin Endocrinol (Oxf)       Date:  1984-10       Impact factor: 3.478

8.  Effects of oral glucose administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH release in children and adults.

Authors:  R Valcavi; M Zini; C Volta; L Ghizzoni; C Azzarito; S Bernasconi; I Portioli
Journal:  J Clin Endocrinol Metab       Date:  1994-10       Impact factor: 5.958

9.  In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose.

Authors:  M Maccario; M Procopio; S Grottoli; S E Oleandri; P Razzore; F Camanni; E Ghigo
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

10.  Paradoxical release of growth hormone during oral glucose tolerance test in patients with abnormal glucose tolerance.

Authors:  E O Grecu; R M Walter; E M Gold
Journal:  Metabolism       Date:  1983-02       Impact factor: 8.694
View more
  1 in total

1.  Characterization of sporadic somatotropinomas with high GIP receptor expression.

Authors:  Olivia Faria; Renan Lyra Miranda; Carlos Henrique de Azeredo Lima; Alexandro Guterres; Nina Ventura; Monique Alvares Barbosa; Aline Helen da Silva Camacho; Elisa Baranski Lamback; Felipe Andreiuolo; Leila Chimelli; Leandro Kasuki; Mônica R Gadelha
Journal:  Pituitary       Date:  2022-09-06       Impact factor: 3.599
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.